JP2023530166A5 - - Google Patents
Info
- Publication number
- JP2023530166A5 JP2023530166A5 JP2022577618A JP2022577618A JP2023530166A5 JP 2023530166 A5 JP2023530166 A5 JP 2023530166A5 JP 2022577618 A JP2022577618 A JP 2022577618A JP 2022577618 A JP2022577618 A JP 2022577618A JP 2023530166 A5 JP2023530166 A5 JP 2023530166A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- composition according
- topical composition
- fluticasone
- corticosteroid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921053286 | 2020-06-15 | ||
| IN201921053286 | 2020-06-15 | ||
| PCT/IB2021/055222 WO2021255622A1 (en) | 2020-06-15 | 2021-06-14 | Combination of alcaftadine and a corticosteroid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023530166A JP2023530166A (ja) | 2023-07-13 |
| JP2023530166A5 true JP2023530166A5 (cg-RX-API-DMAC7.html) | 2024-06-06 |
| JP7791119B2 JP7791119B2 (ja) | 2025-12-23 |
Family
ID=76523259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577618A Active JP7791119B2 (ja) | 2020-06-15 | 2021-06-14 | アルカフタジンとコルチコステロイドの組み合わせ |
Country Status (12)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8580801B2 (en) | 2008-07-23 | 2013-11-12 | Robert I. Henkin | Phosphodiesterase inhibitor treatment |
| WO2015126944A1 (en) | 2014-02-18 | 2015-08-27 | Henkin Robert I | Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell |
| CN115485027A (zh) | 2020-03-24 | 2022-12-16 | 思瑞诺医疗有限公司 | 冠状病毒感染引起的化学感觉功能障碍的治疗 |
| US20240173331A1 (en) * | 2021-04-01 | 2024-05-30 | Alkem Laboratories Limited | Nasal compositions comprising alcaftadine |
| AU2023204805A1 (en) * | 2022-01-06 | 2024-07-25 | Cyrano Therapeutics, Inc. | Improved nasal administration of pharmaceutical formulations |
| WO2024228988A2 (en) * | 2023-05-02 | 2024-11-07 | Cyrano Therapeutics, Inc. | Treatment for taste and smell loss |
| GR1010821B (el) * | 2023-11-09 | 2024-11-15 | Ελπεν Α.Ε. Φαρμακευτικη Βιομηχανια, | Σταθερο ομογενοποιημενο φαρμακευτικο ρινικο εναιωρημα συνδυασμου αζελαστινης και φλουτικαζονης |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE84968T1 (de) | 1987-11-13 | 1993-02-15 | Asta Medica Ag | Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge. |
| IL101850A (en) * | 1991-06-13 | 1996-01-31 | Janssen Pharmaceutica Nv | 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them |
| DE19947234A1 (de) | 1999-09-30 | 2001-04-05 | Asta Medica Ag | Neue Kombination von Loteprednol und Antihistaminika |
| ATE317268T1 (de) | 2001-12-05 | 2006-02-15 | Alcon Inc | Verwendung eines h1-antagonisten und von rimexolon als sicheres steroid zur behandlung von rhinitis |
| PT1919450E (pt) | 2005-09-01 | 2014-09-10 | Meda Ab | Composição lipossomal contendo anti-histamínico e corticosteróide e sua utilização para a preparação de um medicamento para o tratamento de rinite e distúrbios relacionados |
| SG170044A1 (en) * | 2006-03-31 | 2011-04-29 | Vistakon Pharmaceuticals Llc | Ocular allergy treatments |
| US8569273B2 (en) | 2009-03-17 | 2013-10-29 | Aciex Therapeutics, Inc. | Ophthalmic formulations of cetirizine and methods of use |
| WO2011141929A2 (en) * | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| CN102283849A (zh) | 2011-06-29 | 2011-12-21 | 北京阜康仁生物制药科技有限公司 | 一种含有阿卡他定的药物组合物 |
| RU2652352C2 (ru) * | 2012-12-17 | 2018-04-25 | Глаксо Груп Лимитед | Комбинация левокабастина и флутиказона фуроата для лечения воспалительных и/или аллергических состояний |
| UA116793C2 (uk) * | 2013-09-13 | 2018-05-10 | Гленмарк Спешіалті С.А. | Стабільна фармацевтична композиція з фіксованою дозою, що містить мометазон й олопатадин |
| JP7191022B2 (ja) | 2017-07-28 | 2022-12-16 | 参天製薬株式会社 | アルカフタジン又はその塩を含有する水性医薬組成物 |
-
2021
- 2021-06-14 AU AU2021291684A patent/AU2021291684A1/en active Pending
- 2021-06-14 CA CA3181959A patent/CA3181959A1/en active Pending
- 2021-06-14 CN CN202180040805.7A patent/CN115701988A/zh active Pending
- 2021-06-14 WO PCT/IB2021/055222 patent/WO2021255622A1/en not_active Ceased
- 2021-06-14 US US17/997,656 patent/US20230218630A1/en active Pending
- 2021-06-14 KR KR1020227046470A patent/KR20230024928A/ko active Pending
- 2021-06-14 JP JP2022577618A patent/JP7791119B2/ja active Active
- 2021-06-14 MX MX2022015965A patent/MX2022015965A/es unknown
- 2021-06-14 BR BR112022024840A patent/BR112022024840A2/pt unknown
- 2021-06-14 EP EP21733564.5A patent/EP4164614A1/en active Pending
-
2022
- 2022-11-07 ZA ZA2022/12128A patent/ZA202212128B/en unknown
- 2022-12-12 CL CL2022003534A patent/CL2022003534A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Herman | Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost | |
| HRP20200495T1 (hr) | Sastavi za liječenje gastrointestinalne upale | |
| RU2017142694A (ru) | Водная суспензия, содержащая наночастицы глюкокортикостероида | |
| HRP20140864T1 (hr) | Kombinacije koje sadrže antimuskarinska sredstva i beta-adrenergiäśke agoniste | |
| IL216932A (en) | Composition of pharmaceuticals containing azalastine and cyclozonide and method for the manufacture of a periodic allergy treatment containing this composition | |
| SI2393477T1 (en) | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma | |
| JP2010540671A5 (cg-RX-API-DMAC7.html) | ||
| JP2011528355A (ja) | 充血除去剤およびコルチコステロイドを含む鼻腔内粗製物 | |
| JP2015506983A5 (cg-RX-API-DMAC7.html) | ||
| HRP20100104T1 (hr) | Kombinacije koje sadrže antimuskarinska sredstva i kortikosteroide | |
| WO2011141929A2 (en) | Aqueous pharmaceutical compositions of fluticasone and olopatadine | |
| US20090022671A1 (en) | Treatment methods | |
| JP4100713B2 (ja) | 鼻ポリープの治療におけるｈ▲上＋▼，ｋ▲上＋▼―ａｔｐアーゼ阻害剤の使用 | |
| JP2014526448A5 (cg-RX-API-DMAC7.html) | ||
| JP2006518382A5 (cg-RX-API-DMAC7.html) | ||
| Meltzer et al. | New intranasal formulations for the treatment of allergic rhinitis. | |
| Rohatagi et al. | Absolute oral versus inhaled bioavailability: significance for inhaled drugs with special reference to inhaled glucocorticoids | |
| US20070249572A1 (en) | Systems and methods for the delivery of corticosteroids | |
| WO2007075963A2 (en) | Systems and methods for the delivery of corticosteroids | |
| JP2014515360A (ja) | フルチカゾンを含む鼻用医薬製剤 | |
| US20070178050A1 (en) | Methods and systems for the delivery of corticosteroids having an increased lung depositon | |
| US20070197486A1 (en) | Methods and systems for the delivery of corticosteroids | |
| JP2011503109A5 (cg-RX-API-DMAC7.html) | ||
| US20070160542A1 (en) | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile | |
| US20070185066A1 (en) | Systems and methods for the delivery of corticosteroids |